Rockefeller Capital Management’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11K Hold
100
﹤0.01% 4474
2025
Q4
$534 Hold
100
﹤0.01% 4521
2025
Q3
$882 Buy
+100
New +$882 ﹤0.01% 4203

Other funds holding IMUX

Rockefeller Capital Management's IMUX Position: Q1 2026 in Review

Rockefeller Capital Management held its Immunic (IMUX) position steady in Q1 2026 at 100 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #4474.

Rockefeller Capital Management first reported a position in IMUX in Q3 2025 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Rockefeller Capital Management held 100 shares of Immunic worth $1.11K as of Q1 2026.
  • Rockefeller Capital Management left its Immunic share count unchanged in Q1 2026.
  • Immunic made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4474 holding.
  • Rockefeller Capital Management first reported a position in Immunic in Q3 2025 and has held it in 3 quarters since.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.